Vir Biotechnology Future Growth
Future criteria checks 2/6
Vir Biotechnology is forecast to grow earnings and revenue by 5.4% and 23.7% per annum respectively while EPS is expected to grow by 13.8% per annum.
Key information
5.4%
Earnings growth rate
13.8%
EPS growth rate
| Biotechs earnings growth | 0% |
| Revenue growth rate | 23.7% |
| Future return on equity | n/a |
| Analyst coverage | Good |
| Last updated | 16 Nov 2023 |
Recent future growth updates
No updates
Recent updates
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2025 | 56 | -648 | -568 | -544 | 7 |
| 12/31/2024 | 52 | -623 | -557 | -542 | 8 |
| 12/31/2023 | 80 | -651 | -689 | -730 | 8 |
| 9/30/2023 | 119 | -601 | -668 | -636 | N/A |
| 6/30/2023 | 491 | -262 | -410 | -362 | N/A |
| 3/31/2023 | 446 | -144 | 928 | 987 | N/A |
| 12/31/2022 | 1,616 | 516 | 1,595 | 1,663 | N/A |
| 9/30/2022 | 2,379 | 1,143 | 1,567 | 1,636 | N/A |
| 6/30/2022 | 2,108 | 1,078 | 1,357 | 1,412 | N/A |
| 3/31/2022 | 2,326 | 1,216 | 555 | 592 | N/A |
| 12/31/2021 | 1,095 | 529 | -69 | -48 | N/A |
| 9/30/2021 | 284 | -102 | -149 | -137 | N/A |
| 6/30/2021 | 183 | -297 | -88 | -81 | N/A |
| 3/31/2021 | 73 | -390 | -238 | -232 | N/A |
| 12/31/2020 | 76 | -299 | -197 | -191 | N/A |
| 9/30/2020 | 76 | -257 | -153 | -148 | N/A |
| 6/30/2020 | 75 | -220 | -140 | -135 | N/A |
| 3/31/2020 | 10 | -223 | -155 | -149 | N/A |
| 12/31/2019 | 8 | -175 | -139 | -130 | N/A |
| 9/30/2019 | 10 | -137 | -130 | -120 | N/A |
| 6/30/2019 | 12 | -122 | -128 | -118 | N/A |
| 3/31/2019 | 12 | -117 | -119 | -109 | N/A |
| 12/31/2018 | 11 | -116 | -104 | -94 | N/A |
| 12/31/2017 | 3 | -70 | -69 | -66 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: VIR * is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: VIR * is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: VIR * is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: VIR *'s revenue (23.7% per year) is forecast to grow faster than the MX market (6.2% per year).
High Growth Revenue: VIR *'s revenue (23.7% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if VIR *'s Return on Equity is forecast to be high in 3 years time